Clinical effect of tocoretinate on lichen and macular amyloidosis

Lichen amyloidosis and macular amyloidosis are commonly therapy‐resistant. Tocoretinate is a hybrid compound of retinoic acid and tocopherol that is commonly used for the treatment of skin ulcers. Although beneficial effect of oral retinoic acid on lichen amyloidosis is reported, tocoretinate has not been reported to be useful for the treatment of lichen amyloidosis or macular amyloidosis. We evaluated the effects of topical tocoretinate on lichen amyloidosis and macular amyloidosis lesions. Tocoretinate was topically applied daily to the lesions and clinical improvement and histological changes were evaluated. The outcome was very good for four, good for two, moderate for two and poor for two of 10 treated patients. Epidermal hypertrophy was reduced and expression of involucrin, keratin 1 and keratin 10 was decreased by tocoretinate treatment, suggesting the normalization of epidermal differentiation. Amyloid deposits remained histologically detectable, even in clinically responsive patients. Together, topical application of tocoretinate reduced the clinical symptoms of lichen amyloidosis and macular amyloidosis, and normalized disturbed epidermal differentiation.

[1]  S. Kawana,et al.  Lichen amyloidosis of the auricular concha: Successful treatment with electrodesiccation , 2009, The Journal of dermatology.

[2]  H. Tagami,et al.  Lichen amyloidosis induced on the upper back by long‐term friction with a nylon towel , 2009, The Journal of dermatology.

[3]  B. Maddison,et al.  Unexpected diminished innervation of epidermis and dermoepidermal junction in lichen amyloidosus , 2008, The British journal of dermatology.

[4]  Sarthak Gupta,et al.  Dexamethasone cyclophosphamide pulse therapy in lichen amyloidosus: A case report , 2007, The Journal of dermatological treatment.

[5]  K. Scharffetter-Kochanek,et al.  Successful treatment of lichen amyloidosis with combined bath PUVA photochemotherapy and oral acitretin , 2006, Clinical and experimental dermatology.

[6]  S. Shenoi,et al.  Lichen amyloidosus: a study of clinical, histopathologic and immunofluorescence findings in 30 cases. , 2005, Indian journal of dermatology, venereology and leprology.

[7]  M. Akiyama,et al.  A case of lichen amyloidosis treated with pulsed dye laser , 2005, Journal of the European Academy of Dermatology and Venereology.

[8]  S. Halevy,et al.  Lichen amyloidosus treated by hydrocolloid dressings , 2004, Journal of the European Academy of Dermatology and Venereology : JEADV.

[9]  B. Moncada,et al.  Lichen Amyloidosis Improved by 0.1% Topical Tacrolimus , 2002, Dermatology.

[10]  A. García‐Díez,et al.  Widespread biphasic amyloidosis: response to acitretin , 2001, Clinical and experimental dermatology.

[11]  N. Levine,et al.  Lichen amyloidosis associated with atopic dermatitis: clinical resolution with cyclosporine. , 2001, Archives of dermatology.

[12]  H. T. Liu.  Treatment of lichen amyloidosis (LA) and disseminated superficial porokeratosis (DSP) with frequency-doubled Q-switched Nd:YAG laser. , 2000, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[13]  C. Goh,et al.  Calcipotriol ointment vs. betamethasone 17‐valerate ointment in the treatment of lichen amyloidosis , 1999, International journal of dermatology.

[14]  K. Chow,et al.  Apoptosis in primary cutaneous amyloidosis , 1999, The British journal of dermatology.

[15]  H. Mizutani,et al.  Topical Tocoretinate Improved Hypertrophic Scar, Skin Sclerosis in Systemic Sclerosis and Morphea , 1999, The Journal of dermatology.

[16]  G. Özarmaǧan,et al.  Intermittent use of topical dimethyl sulfoxide in macular and papular amyloidosis , 1998, International journal of dermatology.